CGM may provide ‘amazing’ benefits for adults with type 2 diabetes undergoing hemodialysis

Using a continuous glucose monitor improved time in range with no increase in hypoglycemia for people with type 2 diabetes undergoing hemodialysis for end-stage kidney failure, researchers reported in Diabetes Care. “Maintaining adequate glycemic control in people with end-stage kidney disease on hemodialysis is challenging,” Rodolfo J. Galindo, MD, associate professor of medicine at University